Publication | Closed Access
Cost–effectiveness of rivaroxaban versus heparins for prevention of venous thromboembolism after total hip or knee surgery in Sweden
31
Citations
31
References
2011
Year
The results of the economic model consistently showed that, over a 5-year period, rivaroxaban is a cost-effective alternative to 14 days of LMWH for VTE prophylaxis in Sweden.
| Year | Citations | |
|---|---|---|
Page 1
Page 1